Maxwell and NessCap continue bickering over the '544 patent

Over the last four days, the war of words between two ultracapacitor developers, San Diego-based Maxwell Technologies (NasdaqGM:MXWL) and Korean firm NessCap, has reached cacophonous proportions. Each side has issued multiple press releases making and countering claims regarding their interpretation...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Illumina hit with further European Commission antitrust investigations over $8 billion bid for Grail

News Commentary | August 02, 2021

Grail, originally a spinoff of Illumina, develops early‑detection cancer diagnostics using blood samples, which the genomics company seeks to add back into its biotech arsenal. However, both the European Commission and the U.S. Federal Trade Commission argue that the takeover could harm competing ... Not part of subscription

Intel's MobilEye files for IPO

News Commentary | March 10, 2022

MobilEye completed the first step of the IPO process by submitting a draft registration statement to the SEC. Details such as the timing of the IPO, the number of shares, and the price range have not yet been determined. In December 2021, Intel had announced its intent to take MobilEye public and ... Not part of subscription

Umaro’s USD 3 million round will launch plant-based bacon with the ultimate goal of valorizing seaweed

News Commentary | April 07, 2022

Umaro’s recent fundraising aids its ambitions of being a key player in the growing U.S.‑based seaweed market as well as an alternative‑meat producer. The company aims to commercialize its products in Q2 of 2022. The claims of the potential value‑added products held under the ocean’s surface are ... Not part of subscription